Navigation Links
Haemacure Confirms Operation Qualification of Production Equipment and Pursues Milestone Payment from CSL
Date:12/4/2008

HAE:TSX

MONTREAL, Dec. 4 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX:HAE), a Montreal-based specialty bio-therapeutics company developing high-value, human plasma-derived protein products for commercialization, announces that is has confirmed the successful operation qualification of the fibrin sealant production equipment at its new state-of-the-art plasma fractionation facility in Sarasota, Florida.

"I am very excited that we have achieved the important milestone of operation qualification, thus showing clear progress in our transition from a development to a manufacturing company. This allows us to take steps towards the next milestone of producing clinical lots of our lead product candidate, human fibrin sealant, and advancing it to market", said Joseph Galli, Chairman and CEO of Haemacure. "Achieving this milestone also triggers the contractual obligation of CSL Behring AG to pay Haemacure US$1.5 million", concluded Mr. Galli.

The successful operation qualification of the production equipment is one of three milestones the achievement of which obligates CSL Behring AG ("CSL") to pay to Haemacure US$4.5 million in total, pursuant to a settlement agreement entered into in 2002 in relation to its Hemaseel project. The achievement of each milestone obligates CSL to pay Haemacure US$1.5 million. As previously announced, CSL has advised Haemacure that, in its view, it is no longer obligated to make the milestone payments. Haemacure strongly disputes the position of CSL and has, as a result, filed a request for arbitration with the International Court of Arbitration of the International Chamber of Commerce to assert its right to collect the contractual milestone payments and, in particular, the payment due upon the operation qualification of production equipment. Haemacure plans on achieving the second milestone during the first half of 2009 and the third milestone during the following 12 months.

Plasma pro
'/>"/>

SOURCE Haemacure Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Haemacure to Present at the Rodman & Renshaw Annual Global Investor Conference
2. Haemacure Appoints Thomas J. Lynch, J.D., Ph.D. to Board of Directors
3. Adhesion Prevention New Major Market Opportunity, Haemacure Confirms Effectiveness of its Fibrin Sealant in Second Preclinical Study in Adhesion Prevention in a Bleeding Model
4. Haemacure Raises $7.8 Million and is Fully Funded Beyond First-Patient-In-Clinic
5. Haemacure to Present at the BioInternational Convention - The Global Event for Biotechnology - at the San Diego Convention Centre, California, from June 17 - 20, 2008
6. Haemacure Achieves Major Milestone - Starts Processing Plasma in Its New Fractionation Facility
7. Haemacure Reports on Financing Progress and Second Quarter Results
8. Haemacure to Present at Busines$ Meets Finance on May 20, 2008 at the Montreal Sheraton Centre
9. Haemacure announces webcast of presentation at Rodman & Renshaw 5th Annual Global Healthcare Conference
10. Haemacure financing receives shareholder consent - Series B Warrants are amended
11. Haemacure to Present at the BioFinance 2008 Conference to be held at the Toronto Marriott Eaton Centre, May 6 - 8, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2009)...ce or death in middle age may triple the risk, stu... News) -- Middle-aged adults who live alone are tw...isease later in life compared to those who are mar... times higher among those who are divorced or wido...sh researchers. , The study included 2,000 men ...
(Date:7/3/2009)...s Village, ( http://www.EvasVillage.org ), the Pat...rs for 35mm Michael Jackson Film Print of "Th... Paterson, NJ (PRWEB) July 3, 2009 -- Eva,s Vill...ew Jersey anti-poverty charity, seeks serious inqu... Jackson,s "Thriller" music video., , ,...
(Date:7/3/2009)...an Whitaker, MD, a founder of the alternative heal...ntpain.com, a new informational Web site devoted t...olutions. , Potomac, MD (...der of the alternative health movement, is now a f...mational Web site devoted to all aspects of joint ...
(Date:7/2/2009)...e-USNewswire/ -- Recent news reports have highligh...suring that physicians meet high standards in thei...an Board of Medical Specialties (ABMS), which coor...efforts to develop and implement educational and p...fication of physician specialists. Certification ...
Breaking Medicine News(10 mins):Health News:Living Alone Increases Odds of Developing Dementia 2Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 2Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 3Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 4Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 5Health News:Dr. Julian Whitaker Featured on Searchjointpain.com 2Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 2Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 3Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 4
...as stressed the need to revamp the Mental Health A...mentally ill women// ; nearly five million women i...al health in 21st century is a great threat. We th... law and broaden the scope of mental health," said...
...unshine is good for the development of the human b...euven, // Belgium reconfirmed this idea. The study...ctually help protect an unborn baby from diabetes ...h of it could actually turn out to be harmful. &...
...e have discovered a tiny bacterium that could one ...phenyls (PCBs) from our environment//. The organis... detoxify commercial PCB compounds on site — witho... will appear in the April 15 issue of Applied and ...
...day has indicated the need for a cardiac departmen...cunae// in the care meted out to patients who have...kay Base Hospital. Mackay Base Hospital was found ...in 22 of the 26 categories but portrayed some worr...
Other Medicine News:Health News:Five Million Indian Women Suffer Mental Illness 2Health News:Bacterium Could Treat PCBs Without the Need for Dredging 2
(Date:7/2/2009)...ly 3 ,ThromboGenics NV (...,BioInvent International (OMXS: BINV) announce th...rt of patients for their Phase II trial of,TB-402...rst cohort of 100,patients ahead of schedule. TB-... being developed for the prevention of deep vein t...
(Date:7/2/2009)...PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Toky...Eisai Corporation of North America (Headquarters: ...u) are currently focusing on three clinical develo...cept(R) (donepezil hydrochloride tablets) to furth.... As progress in those programs has been made, Eis...
(Date:7/1/2009)...ire-FirstCall/ -- A just published,Review in the ...gs", Volume,18, Issue 7 2009, confirms the previo... the most comprehensive and updated Review on,PRO... "Preliminary clinical trials have indicated,negl...d a survival benefit,after treatment with PROSTVA...
(Date:6/30/2009)... In two recent COPD studies sponsored by DEY LP, P...tra and Ultra II) were used to show that nebulized...nc.) improves pulmonary function. , , "We are ...e exclusive nebulizer systems for recent studies c...and et al. used an open-label crossover design all...
Breaking Medicine Technology:ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402 2ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402 3ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402 4ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402 5Current Status of the Development Programs of New Indications and Formulations for Aricept(R) for Enhancing Patient Value 2Current Status of the Development Programs of New Indications and Formulations for Aricept(R) for Enhancing Patient Value 3New Review on PROSTVAC(TM) Published by Key Investigators From NCI 2PARI LC Plus and PRONEB Ultra Used in Two Perforomist Studies on Improving COPD Therapies 2Gaining Too Much Weight During Pregnancy Nearly Doubles Risk of Having a Heavy Baby 3373 1Gaining Too Much Weight During Pregnancy Nearly Doubles Risk of Having a Heavy Baby 3373 2Gaining Too Much Weight During Pregnancy Nearly Doubles Risk of Having a Heavy Baby 3373 3Ultrafast lasers give CU Boulder researchers a snapshot of electrons in action 8771 1Ultrafast lasers give CU Boulder researchers a snapshot of electrons in action 8771 2Gentiva 28R 29 Health Services to Present at November Investment Conferences Hosted by Oppenheimer Credit Suisse and Stephens 28358 1Gentiva 28R 29 Health Services to Present at November Investment Conferences Hosted by Oppenheimer Credit Suisse and Stephens 28358 2Gentiva 28R 29 Health Services to Present at November Investment Conferences Hosted by Oppenheimer Credit Suisse and Stephens 28358 3Consumers Union Urges FDA to Conduct Full Scale Safety Review of Nanoparticles in Sunscreen 28354 1Consumers Union Urges FDA to Conduct Full Scale Safety Review of Nanoparticles in Sunscreen 28354 2
Obwegeser periosteal elevator, angled, 9 mm, 20 cm, 8".
...tem unites the clinical experience of Monarch, Ka...ology developed specifically for thoracoscopic pro...city and security. Frontier provides surgeons the ...ity from an anterior approach. Instrumentation is ...
..., and screw system designed to treat various patho...m utilizes a low profile design that incorporates ...re mechanism. The load sharing design of the 5.5 T...le to be applied when used with proper anterior co...
...ontinuously and displays perfusion data from the p...de, the monitor periodically performs in situ cali.... The rules may be changed for particular situatio...emperature, is displayed graphically as a function...
Medicine Products: